CD
NTRP

Carl Domino’s Neurotrope, Inc. Common NTRP Stock Holding History

Carl Domino’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$75K Buy
+14,563
New +$76.4K 0.09% 112

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Carl Domino's NTRP Position: Q3 2017 in Review

Carl Domino opened a new position in Neurotrope, Inc. Common (NTRP) in Q3 2017: 14,563 shares worth $75K. The stake represents 0.09% of the portfolio and ranks #112 among its holdings.

23 funds tracked by Wall St. Rank hold NTRP as of Q3 2017.

  • Carl Domino held 14,563 shares of Neurotrope, Inc. Common worth $75K as of Q3 2017.
  • Neurotrope, Inc. Common was a new Carl Domino position in Q3 2017.
  • Neurotrope, Inc. Common made up 0.09% of Carl Domino's portfolio in Q3 2017, its #112 holding.
  • 23 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q3 2017.

Based on Carl Domino's 13F filing for Q3 2017, filed 7 Nov 2017.